H. Choy

2.7k total citations
108 papers, 2.0k citations indexed

About

H. Choy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, H. Choy has authored 108 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 52 papers in Oncology and 21 papers in Radiation. Recurrent topics in H. Choy's work include Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Diagnosis and Treatment (52 papers) and Lung Cancer Research Studies (28 papers). H. Choy is often cited by papers focused on Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Diagnosis and Treatment (52 papers) and Lung Cancer Research Studies (28 papers). H. Choy collaborates with scholars based in United States, Canada and France. H. Choy's co-authors include Michael Glantz, Wallace Akerley, Howard Safran, Bernard F. Cole, Jeffrey D. Bradley, Ritsuko Komaki, Robert Timmerman, Gregory M.M. Videtic, Stephen L. Graziano and T. Kennedy and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

H. Choy

103 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Choy United States 25 1.5k 973 516 341 229 108 2.0k
Mark B. Hazuka United States 23 1.4k 0.9× 638 0.7× 652 1.3× 490 1.4× 398 1.7× 41 2.1k
Daniela Greto Italy 22 797 0.5× 571 0.6× 385 0.7× 397 1.2× 319 1.4× 126 1.8k
Najeeb Mohideen United States 17 1.0k 0.7× 380 0.4× 369 0.7× 148 0.4× 302 1.3× 36 1.4k
Charlie C. Pan United States 19 1.1k 0.8× 525 0.5× 839 1.6× 668 2.0× 619 2.7× 28 2.3k
B. Maat Netherlands 12 1.2k 0.8× 635 0.7× 304 0.6× 328 1.0× 274 1.2× 21 2.1k
J.H. Heinzerling United States 15 748 0.5× 330 0.3× 501 1.0× 346 1.0× 151 0.7× 56 1.2k
Mauro Loi Italy 23 716 0.5× 586 0.6× 300 0.6× 321 0.9× 284 1.2× 124 1.5k
Stephen G. Chun United States 19 981 0.7× 687 0.7× 375 0.7× 363 1.1× 265 1.2× 67 1.6k
Farkhad Manapov Germany 20 915 0.6× 540 0.6× 292 0.6× 440 1.3× 95 0.4× 107 1.3k
L. Dewit Netherlands 23 666 0.5× 506 0.5× 186 0.4× 550 1.6× 509 2.2× 58 1.8k

Countries citing papers authored by H. Choy

Since Specialization
Citations

This map shows the geographic impact of H. Choy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Choy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Choy more than expected).

Fields of papers citing papers by H. Choy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Choy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Choy. The network helps show where H. Choy may publish in the future.

Co-authorship network of co-authors of H. Choy

This figure shows the co-authorship network connecting the top 25 collaborators of H. Choy. A scholar is included among the top collaborators of H. Choy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Choy. H. Choy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chun, Stephen G., Chen Hu, H. Choy, et al.. (2023). OA17.04 Long-Term Outcomes by Radiation Technique for Locally-Advanced Non-small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years. Journal of Thoracic Oncology. 18(11). S83–S84. 1 indexed citations
2.
Sun, A., Chen Hu, Elizabeth Gore, et al.. (2018). OA01.01 10-Year Updated Analysis of NRG Oncology/RTOG 0214: A Phase III Comparison of PCI vs. Observation in Patients with LA-NSCLC.. Journal of Thoracic Oncology. 13(10). S319–S319.
3.
Iyengar, Puneeth, Kenneth D. Westover, Laurence E. Court, et al.. (2016). A Phase III Randomized Study of Image Guided Conventional (60 Gy/30 fx) Versus Accelerated, Hypofractionated (60 Gy/15 fx) Radiation for Poor Performance Status Stage II and III NSCLC Patients—An Interim Analysis. International Journal of Radiation Oncology*Biology*Physics. 96(2). E451–E451. 13 indexed citations
4.
Blumenschein, George R., Jennifer Moughan, Walter J. Curran, et al.. (2007). B3-07: A phase II study of Cetuximab (C225) in combination with chemoradiation. Journal of Thoracic Oncology. 2(8). S342–S343. 4 indexed citations
5.
Choy, H. & Everett E. Vokes. (2005). Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine. Lung Cancer. 50. S10–S12. 1 indexed citations
6.
Choy, H., et al.. (2003). Potential for Combined Modality Therapy of Cyclooxygenase Inhibitors and Radiation. PubMed. 37. 193–209. 10 indexed citations
7.
Choy, H.. (2003). Chemotherapy and irradiation interaction. Seminars in Oncology. 30(4 Suppl 9). 3–10. 24 indexed citations
8.
Movsas, Benjamin, Jennifer Moughan, Ritsuko Komaki, et al.. (2002). Radiotherapy (RT) patterns of care study (PCS) in lung carcinoma. International Journal of Radiation Oncology*Biology*Physics. 54(2). 101–102. 4 indexed citations
9.
Choy, H.. (2001). The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancer. Seminars in Oncology. 28(4 Suppl 14). 17–22. 17 indexed citations
10.
11.
Choy, H., Wallace Akerley, & Ronald DeVore. (1998). Paclitaxel, carboplatin and radiation therapy for non-small-cell lung cancer.. PubMed. 12(1 Suppl 2). 80–6. 7 indexed citations
12.
Choy, H., Wallace Akerley, Howard Safran, et al.. (1998). Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 16(10). 3316–3322. 190 indexed citations
13.
Akerley, Wallace, Michael Glantz, H. Choy, et al.. (1998). Phase I trial of weekly paclitaxel in advanced lung cancer.. Journal of Clinical Oncology. 16(1). 153–158. 102 indexed citations
14.
Glantz, Michael, H. Choy, Wallace Akerley, et al.. (1997). Weekly paclitaxel with and without concurrent radiation therapy: Toxicity, pharmacokinetics, and response. Seminars in Radiation Oncology. 7. 7 indexed citations
15.
Safran, Howard, H. Choy, Paul J. Hesketh, et al.. (1997). Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.. Journal of Clinical Oncology. 15(3). 901–907. 67 indexed citations
16.
Choy, H., et al.. (1996). Concurrent Paclitaxel and Radiation Therapy for Solid Tumors. Cancer Control. 3(4). 310–318. 14 indexed citations
17.
Glantz, Michael, Bernard F. Cole, Marc H. Friedberg, et al.. (1996). A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology. 46(4). 985–991. 141 indexed citations
18.
Glantz, Michael, H. Choy, Christine M. Kearns, et al.. (1995). Paclitaxel Disposition in Plasma and Central Nervous Systems of Humans and Rats With Brain Tumors. JNCI Journal of the National Cancer Institute. 87(14). 1077–1081. 92 indexed citations
19.
Choy, H., Wallace Akerley, Howard Safran, et al.. (1994). Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 12(12). 2682–2686. 116 indexed citations
20.
Choy, H., et al.. (1991). Analysis of GSH from primary tumors and its role in in vitro chemosensitivities. Investigational New Drugs. 9(4). 327–328. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark B. Hazuka Breakdown of academic impact, for papers by Daniela Greto Breakdown of academic impact, for papers by Najeeb Mohideen Breakdown of academic impact, for papers by Charlie C. Pan Breakdown of academic impact, for papers by B. Maat Breakdown of academic impact, for papers by J.H. Heinzerling Breakdown of academic impact, for papers by Mauro Loi Breakdown of academic impact, for papers by Stephen G. Chun Breakdown of academic impact, for papers by Farkhad Manapov Breakdown of academic impact, for papers by L. Dewit
Rankless by CCL
2026